about
Evolutionary dynamics of cancer in response to targeted combination therapySimilar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistanceBioinformatics for cancer immunology and immunotherapyCancer evolution: mathematical models and computational inferenceTracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations.The challenges of tumor genetic diversity.Modeling Tumor Clonal Evolution for Drug Combinations DesignHigh-definition reconstruction of clonal composition in cancerTiming and heterogeneity of mutations associated with drug resistance in metastatic cancersThe value of monitoring to control evolving populationsA new model of time scheme for progression of colorectal cancer.Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution.Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.The impact of cell density and mutations in a model of multidrug resistance in solid tumors.Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.Hsp90, an unlikely ally in the war on cancer.Differential selective pressure alters rate of drug resistance acquisition in heterogeneous tumor populations.Mathematical models for translational and clinical oncology.Stochastic model of contact inhibition and the proliferation of melanoma in situVertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers.A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity.Evolutionary scalpels for dissecting tumor ecosystems.Sigma1 Pharmacology in the Context of Cancer.The effect of one additional driver mutation on tumor progression.Non-coding RNA networks in cancer.
P2860
Q21128788-E9A5EB1C-D636-41B8-9E53-83C6EA5A35AFQ26795609-48B0ACE5-AFF7-4567-B8DF-FCB0CE8A63A4Q26864876-9B636E15-91B2-4EF0-A54A-917A5CFB6C91Q27002537-E927FDB4-99CA-4D1D-911B-C41A47ED79B3Q27335464-9F4D03FD-506E-49FB-90EB-511DF26C4A4DQ30241056-9552C7CD-49CB-4E0F-95E8-A40B3708B81DQ33590430-FF83B601-48BE-4141-B239-1DE70BAF588AQ33775654-944CEF18-5BD6-4D3B-A927-1BF5D3DF7F10Q34525966-32A8B6D4-B1A7-47AC-9878-5E79D0F0B703Q35038019-CE7FA086-F744-4661-90FD-F094060D1A81Q35372337-42E483B6-8884-48DD-8AA1-FF5733D137CEQ35909370-3BF7A74A-C12F-4A3C-917D-3F042975033EQ36412928-980A41A8-43F0-4985-96DA-54CAECC4BE67Q36692520-EAA64DD4-1EF1-4B98-A9B1-BAD3493C750CQ36952837-12B9A3F6-DA0E-48D3-A6F8-5059B1A89EC9Q37274497-B9505774-00A5-4122-9E13-0C8D9F7B30F1Q37397222-2D57766B-987E-41F7-872B-1D3245B892BFQ38160282-69BAB3EF-AA4E-4C0E-9461-009619C0E38AQ38694927-974B397D-D4AE-4924-A8C0-75FF7D9B2C46Q38833684-1E6B75FC-D0D3-4EBD-AD35-C51A738D2A6FQ38843089-C8BC5873-35EE-42E8-A705-2F6E7898C04FQ39030938-36F336D7-DFCA-4781-BE25-06847362F66BQ39458668-25754F30-1CB7-40F4-91D1-4765F47134DEQ41846748-95B63C5D-6B1F-4ECA-9094-C88D572D8FA9Q49689803-A31B40D9-153A-48E7-A1C2-369DF629FC3B
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Dynamics of targeted cancer therapy
@en
Dynamics of targeted cancer therapy
@nl
type
label
Dynamics of targeted cancer therapy
@en
Dynamics of targeted cancer therapy
@nl
prefLabel
Dynamics of targeted cancer therapy
@en
Dynamics of targeted cancer therapy
@nl
P2860
P1476
Dynamics of targeted cancer therapy
@en
P2093
Martin A Nowak
P2860
P304
P356
10.1016/J.MOLMED.2012.04.006
P577
2012-05-15T00:00:00Z